The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-3-hydroxypropyl 6-chloro-4-(1-cyclopropylethyl)-3-oxo-3,4-dihydropyrazin-2-yl(2,6-dichloro-4-(difluoromethoxy)phenyl)carbamate ID: ALA4087161
PubChem CID: 137643390
Max Phase: Preclinical
Molecular Formula: C20H20Cl3F2N3O5
Molecular Weight: 526.75
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H](C1CC1)n1cc(Cl)nc(N(C(=O)OCCCO)c2c(Cl)cc(OC(F)F)cc2Cl)c1=O
Standard InChI: InChI=1S/C20H20Cl3F2N3O5/c1-10(11-3-4-11)27-9-15(23)26-17(18(27)30)28(20(31)32-6-2-5-29)16-13(21)7-12(8-14(16)22)33-19(24)25/h7-11,19,29H,2-6H2,1H3/t10-/m0/s1
Standard InChI Key: SKAYQQFMGIMCKB-JTQLQIEISA-N
Molfile:
RDKit 2D
33 35 0 0 0 0 0 0 0 0999 V2000
2.9459 -15.6336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9459 -16.4586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6579 -16.8669 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3699 -16.4586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3699 -15.6336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6579 -15.2169 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6579 -14.3918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3724 -13.9794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9434 -13.9794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1958 -13.9794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7833 -13.2649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2320 -16.8722 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5.0838 -16.8722 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0856 -15.2231 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0826 -17.6972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3665 -18.1069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3650 -18.9312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0794 -19.3455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7969 -18.9297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7948 -18.1068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6532 -17.6923 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.5085 -17.6927 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5.0793 -20.1705 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3648 -20.5829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6503 -20.1703 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.3647 -21.4080 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.7989 -16.4607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5127 -16.8742 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8001 -15.6356 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2278 -16.4628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9418 -16.8763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6569 -16.4648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3707 -16.8783 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 6 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
7 9 1 1
10 8 1 0
11 10 1 0
8 11 1 0
2 12 1 0
4 13 1 0
5 14 2 0
13 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
16 21 1 0
20 22 1 0
18 23 1 0
23 24 1 0
24 25 1 0
24 26 1 0
13 27 1 0
27 28 1 0
27 29 2 0
28 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 526.75Molecular Weight (Monoisotopic): 525.0437AlogP: 5.43#Rotatable Bonds: 9Polar Surface Area: 93.89Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.70CX LogD: 4.70Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.44Np Likeness Score: -0.75
References 1. Hartz RA, Vrudhula VM, Ahuja VT, Grace JE, Lodge NJ, Bronson JJ, Macor JE.. (2017) Synthesis and evaluation of prodrugs of corticotropin-releasing factor-1 (CRF1) receptor antagonist BMS-665053 leading to improved oral bioavailability., 27 (6): [PMID:28223020 ] [10.1016/j.bmcl.2017.02.015 ]